Complete Filing Data
Origin Materials, Inc. reported Stockholders Equity of $104.21 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Origin Materials, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$249.7M | -$83.7M | $23.8M | $78.6M | $42.1M | -$30.3M |
| Nonoperating Income Expense | $10.0M | $1.8M | $77.6M | $117.5M | $69.0M | -$19.1M |
| Research And Development Expense | $13.7M | $18.6M | $21.4M | $14.1M | $9.1M | $4.1M |
| Operating Expenses | $259.6M | $85.3M | $60.1M | $38.9M | $26.9M | $11.2M |
| General And Administrative Expense | $39.1M | $40.8M | $35.4M | $24.1M | $17.3M | $6.6M |
| Comprehensive Income Net Of Tax | -$243.3M | -$94.5M | $33.8M | $63.9M | $40.5M | -$29.5M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $679.0K | $2.2M | $6.4M | -$8.0M | -$1.7M | $0.00 |
| Operating Income Loss | -$259.1M | -$84.9M | -$54.9M | -$38.9M | -$341.6K | |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $6.4M | -$10.8M | $10.0M | -$14.7M | ||
| Research And Development Program Liability Noncurrent | $16.8M | $14.4M | $7.3M | $7.2M | $6.8M | $6.2M |
| Revenues | $18.9M | $31.3M | $28.8M | $0.00 | ||
| Other Nonoperating Income Expense | -$726.0K | -$939.0K | $838.0K | $1.7M | ||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $5.7M | -$13.0M | $3.7M | -$6.7M | ||
| Income Tax Expense Benefit | $621.0K | $669.0K | -$1.1M | $0.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$249.1M | -$83.0M | $22.7M | $78.6M | ||
| Interest Expense | $131.0K | $0.00 | $2.8M | $341.0K | ||
| Cost Of Revenue |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$16.4M | -$12.7M | -$26.4M | -$36.8M | -$19.5M | -$13.9M | $30.9M | -$6.5M | $9.8M | $8.3M | $46.9M | $7.3M | $27.9M | $62.5M | -$53.6M | -$3.1M | -$1.7M | -$2.0M |
| Nonoperating Income Expense | $630.0K | $2.3M | $6.2M | -$4.1M | -$1.2M | $4.2M | $43.2M | $7.9M | $22.0M | $18.0M | $55.6M | $14.9M | $35.0M | $69.2M | -$48.2M | -$1.1M | $14.0K | |
| Research And Development Expense | $3.3M | $3.3M | $3.3M | $5.1M | $4.4M | $5.8M | $4.9M | $5.4M | $5.1M | $3.7M | $2.6M | $2.3M | $2.0M | $2.3M | $1.3M | $1.2M | $904.0K | |
| Operating Expenses | $17.1M | $15.1M | $32.7M | $32.5M | $18.5M | $18.1M | $12.9M | $14.4M | $13.0M | $9.7M | $8.7M | $7.6M | $7.1M | $6.7M | $5.4M | $2.0M | $1.7M | |
| General And Administrative Expense | $10.7M | $9.1M | $10.1M | $9.3M | $11.3M | $10.0M | $7.6M | $8.6M | $7.7M | $5.8M | $5.9M | $5.1M | $5.0M | $4.2M | $3.9M | $737.0K | $703.0K | |
| Comprehensive Income Net Of Tax | -$18.6M | -$5.8M | -$26.0M | -$34.2M | -$20.2M | -$17.2M | $28.3M | -$1.7M | $11.3M | -$357.0K | $40.4M | $3.7M | $26.8M | $63.2M | -$53.1M | -$6.7M | $4.1M | |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $311.0K | $224.0K | $159.0K | $690.0K | $950.0K | $570.0K | $1.6M | $1.5M | $1.4M | -$1.4M | -$4.8M | -$4.6M | $0.00 | $0.00 | $0.00 | |||
| Operating Income Loss | -$16.9M | -$15.0M | -$32.6M | -$32.4M | -$18.3M | -$18.0M | -$12.1M | -$14.3M | -$12.3M | -$9.7M | -$8.7M | -$7.6M | -$911.8K | -$140.3K | -$9.1K | |||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$2.2M | $6.9M | $395.0K | $2.5M | -$741.0K | -$3.3M | -$2.6M | $4.8M | $1.5M | -$8.7M | -$6.5M | -$3.7M | ||||||
| Research And Development Program Liability Noncurrent | $14.9M | $15.1M | $14.4M | $15.3M | $15.1M | $15.3M | $7.2M | $7.3M | $7.2M | $6.3M | $6.7M | $6.9M | $6.5M | $6.4M | ||||
| Revenues | $4.7M | $5.8M | $5.4M | $8.2M | $7.0M | $6.8M | $7.1M | $6.9M | $1.7M | $0.00 | $0.00 | $0.00 | ||||||
| Other Nonoperating Income Expense | -$396.0K | $128.0K | -$119.0K | -$517.0K | -$645.0K | -$8.0K | $2.6M | $420.0K | -$1.4M | $879.0K | $247.0K | $450.0K | ||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$2.5M | $6.7M | $236.0K | $1.8M | -$1.7M | -$3.8M | -$4.2M | $3.3M | $120.0K | -$7.3M | -$1.7M | $885.0K | ||||||
| Income Tax Expense Benefit | $78.0K | $120.0K | $59.0K | $231.0K | $54.0K | $118.0K | $94.0K | $129.0K | $0.00 | $0.00 | $0.00 | |||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$16.3M | -$12.6M | -$26.4M | -$36.5M | -$19.4M | -$13.8M | $31.0M | -$6.3M | $9.8M | $8.3M | $46.9M | |||||||
| Interest Expense | $117.0K | $2.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.6M | $280.0K | $54.0K | $50.0K | |||||||
| Cost Of Revenue | $6.3M | $6.8M | $960.0K | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $104.2M | $338.4M | $422.5M | $376.9M | $303.5M | $123.0K | $28.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $32.9M | $56.3M | $75.5M | $108.3M | $47.1M | $1.9M | $3.6M |
| Retained Earnings Accumulated Deficit | -$287.8M | -$38.1M | $45.6M | $21.8M | -$56.8M | -$98.9M | |
| Cash And Cash Equivalents At Carrying Value | $32.9M | $56.3M | $75.5M | $107.9M | $46.6M | $1.3M | |
| Change In Fair Value Of Earnout Liability | $2.5M | -$703.0K | $41.0M | $85.4M | $75.5M | $0.00 | |
| Liabilities And Stockholders Equity | $157.7M | $378.0M | $461.8M | $493.7M | $510.4M | $47.4M | |
| Assets | $157.7M | $378.0M | $461.8M | $493.7M | $510.4M | $47.4M | |
| Liabilities | $53.4M | $39.7M | $39.3M | $116.8M | $206.9M | $47.3M | |
| Assets Current | $80.9M | $139.2M | $187.1M | $331.5M | $451.2M | $2.0M | |
| Liabilities Current | $28.5M | $12.5M | $12.9M | $19.8M | $4.2M | $7.8M | |
| Accrued Liabilities Current | $4.9M | $2.8M | $7.7M | $8.4M | $973.0K | $593.0K | |
| Change In Fair Value Of Warrant Liability | -$22.0M | $4.5M | $18.5M | ||||
| Common Stock Value | $15.0K | $15.0K | $15.0K | $14.0K | $16.0K | $6.0K | |
| Change In Fair Value Of Common Stock Warrants Liability | $4.4M | -$3.2M | $29.5M | $22.0M | -$30.5M | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$23.4M | -$19.2M | -$32.8M | $61.2M | $45.3M | -$1.7M | |
| Property Plant And Equipment Net | $72.9M | $203.9M | $243.1M | $154.2M | $57.2M | $45.1M | |
| Prepaid Expense And Other Assets Current | $2.4M | $2.4M | $8.4M | $3.3M | $3.8M | $83.0K | |
| Other Receivables Net Current | $2.1M | $2.5M | $3.4M | $4.3M | $2.6M | $48.0K | |
| Other Liabilities Noncurrent | $30.0K | $74.0K | $8.3M | $8.3M | $2.9M | $2.5M | |
| Intangible Assets Net Excluding Goodwill | $32.0K | $73.0K | $121.0K | $160.0K | $215.0K | $258.0K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$10.4M | -$16.7M | -$5.9M | -$16.0M | -$1.3M | $384.0K | |
| Accounts Payable Current | $3.6M | $2.9M | $1.9M | $10.4M | $2.5M | $2.7M | |
| Unsecured Long Term Debt | $24.0K | $2.5M | $1.8M | $42.5M | $127.8M | $0.00 | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Other Liabilities Current | $231.0K | $2.8M | $918.0K | $51.0K | $380.0K | $0.00 | |
| Other Assets Noncurrent | $751.0K | $30.5M | $25.8M | $5.1M | $62.0K | $62.0K | |
| Operating Lease Right Of Use Asset | $3.1M | $3.7M | $4.5M | $2.8M | $1.8M | $0.00 | |
| Operating Lease Liability Noncurrent | $3.5M | $3.9M | $4.2M | $2.2M | $1.5M | $0.00 | |
| Operating Lease Liability Current | $306.0K | $323.0K | $367.0K | $619.0K | $280.0K | $0.00 | |
| Available For Sale Securities Debt Securities Current | $20.5M | $46.6M | $82.8M | $215.5M | $397.5M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $295.0M | $311.1M | $314.6M | $358.9M | $390.6M | $408.2M | $424.1M | $392.5M | $391.1M | $352.0M | $350.9M | $308.4M | $299.0M | $271.5M | -$52.3M | $20.3M | $27.0M | $22.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $34.1M | $35.3M | $43.8M | $56.4M | $55.7M | $75.8M | $66.1M | $66.0M | $87.4M | $103.5M | $79.5M | $58.4M | $459.8M | $470.9M | $9.4M | $988.0K | $2.2M | |
| Retained Earnings Accumulated Deficit | -$93.7M | -$77.3M | -$64.6M | -$24.6M | $12.2M | $31.7M | $56.0M | $25.1M | $31.5M | $5.8M | -$2.5M | -$49.5M | -$62.0M | -$89.9M | -$9.7M | -$71.3K | -$9.1K | |
| Cash And Cash Equivalents At Carrying Value | $34.1M | $35.3M | $43.8M | $56.4M | $55.7M | $75.8M | $66.1M | $65.5M | $87.0M | $103.0M | $79.1M | $57.9M | $459.3M | $470.3M | $359.1K | $1.3M | $0.00 | |
| Change In Fair Value Of Earnout Liability | $0.00 | $0.00 | $2.5M | -$2.9M | -$978.0K | $1.5M | $18.8M | $7.5M | $12.9M | $15.1M | $33.2M | $15.2M | $21.5M | $45.5M | $0.00 | $0.00 | ||
| Liabilities And Stockholders Equity | $327.3M | $348.4M | $349.0M | $399.6M | $431.0M | $448.6M | $471.0M | $476.7M | $483.5M | $492.5M | $498.8M | $505.6M | $514.1M | $520.4M | $725.4M | $726.1M | $597.6K | |
| Assets | $327.3M | $348.4M | $349.0M | $399.6M | $431.0M | $448.6M | $471.0M | $476.7M | $483.5M | $492.5M | $498.8M | $505.6M | $514.1M | $520.4M | $725.4M | $726.1M | $597.6K | |
| Liabilities | $32.4M | $37.3M | $34.4M | $40.7M | $40.3M | $40.5M | $47.0M | $84.2M | $92.3M | $140.4M | $147.9M | $197.2M | $215.1M | $248.9M | $86.5M | $25.4M | ||
| Assets Current | $84.1M | $101.6M | $119.5M | $141.4M | $161.4M | $176.7M | $209.2M | $236.1M | $277.0M | $372.8M | $413.0M | $433.3M | $463.9M | $471.3M | $600.9K | $1.6M | ||
| Liabilities Current | $13.3M | $15.9M | $12.6M | $8.7M | $11.9M | $14.0M | $16.7M | $12.1M | $15.0M | $16.2M | $9.6M | $7.0M | $2.9M | $1.8M | $168.6K | $581.6K | ||
| Accrued Liabilities Current | $8.9M | $11.4M | $6.9M | $3.2M | $3.3M | $5.4M | $7.1M | $4.4M | $5.7M | $5.4M | $3.4M | $2.5M | $1.1M | $861.0K | $9.1K | |||
| Change In Fair Value Of Warrant Liability | -$22.8M | $2.1M | -$6.8M | $1.4M | -$18.8M | $1.8M | -$13.5M | -$27.3M | $48.1M | $1.0M | $105.0K | |||||||
| Common Stock Value | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $16.0K | $13.0K | $13.0K | ||||
| Change In Fair Value Of Common Stock Warrants Liability | $163.0K | $1.1M | $2.8M | -$2.3M | -$1.3M | $649.0K | $22.8M | -$2.1M | $6.8M | $1.8M | $0.00 | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$12.5M | $271.0K | -$20.9M | $11.3M | $7.6M | |||||||||||||
| Property Plant And Equipment Net | $225.7M | $229.1M | $211.6M | $222.8M | $233.6M | $238.2M | $234.1M | $220.8M | $190.7M | $111.4M | $82.3M | $69.3M | $50.0M | $48.9M | ||||
| Prepaid Expense And Other Assets Current | $2.0M | $1.8M | $2.1M | $3.9M | $8.2M | $8.4M | $6.0M | $3.3M | $3.9M | $5.2M | $2.7M | $2.6M | $3.9M | $214.0K | ||||
| Other Receivables Net Current | $2.5M | $2.7M | $3.1M | $5.2M | $4.6M | $4.2M | $1.9M | $6.8M | $6.4M | $3.5M | $3.0M | $2.8M | $262.0K | $160.0K | ||||
| Other Liabilities Noncurrent | $41.0K | $54.0K | $63.0K | $2.6M | $2.6M | $2.6M | $8.3M | $8.9M | $8.8M | $2.9M | $2.8M | $2.9M | $3.0M | $3.1M | ||||
| Intangible Assets Net Excluding Goodwill | $51.0K | $60.0K | $65.0K | $88.0K | $97.0K | $108.0K | $129.0K | $142.0K | $150.0K | $168.0K | $190.0K | $206.0K | $225.0K | $242.0K | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$11.6M | -$9.4M | -$16.3M | -$7.4M | -$9.9M | -$9.2M | -$12.2M | -$9.6M | -$14.4M | -$20.1M | -$11.4M | -$4.9M | $408.0K | $1.5M | ||||
| Accounts Payable Current | $1.9M | $2.1M | $3.2M | $1.3M | $1.8M | $2.0M | $5.0M | $6.8M | $7.9M | $7.6M | $4.6M | $3.1M | $1.8M | $966.0K | ||||
| Unsecured Long Term Debt | $24.0K | $24.0K | $24.0K | $4.2M | $1.2M | $265.0K | $3.6M | $22.4M | $29.9M | $64.2M | $79.3M | $112.5M | $136.2M | $157.6M | ||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Other Liabilities Current | $387.0K | $441.0K | $410.0K | $93.0K | $1.1M | $973.0K | $2.9M | $397.0K | $731.0K | $2.6M | $869.0K | $90.0K | ||||||
| Other Assets Noncurrent | $13.7M | $13.8M | $13.8M | $30.6M | $30.7M | $28.2M | $23.0M | $17.2M | $13.0M | $5.1M | $62.0K | $95.0K | ||||||
| Operating Lease Right Of Use Asset | $3.3M | $3.4M | $3.4M | $3.8M | $4.2M | $4.3M | $4.6M | $2.5M | $2.6M | $3.0M | $3.2M | $2.7M | ||||||
| Operating Lease Liability Noncurrent | $3.6M | $3.7M | $3.8M | $3.9M | $4.0M | $4.1M | $4.3M | $2.0M | $2.1M | $2.5M | $2.7M | $2.3M | ||||||
| Operating Lease Liability Current | $331.0K | $336.0K | $334.0K | $305.0K | $305.0K | $323.0K | $404.0K | $611.0K | $624.0K | $599.0K | $624.0K | $412.0K | ||||||
| Available For Sale Securities Debt Securities Current | $20.3M | $34.1M | $39.2M | $57.0M | $76.5M | $70.9M | $123.4M | $152.2M | $177.0M | $258.7M | $327.1M | $369.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Increase Decrease In Accrued Liabilities | $1.5M | -$3.6M | $5.0M | $485.0K | $3.0M | $349.0K |
| Net Cash Provided By Used In Operating Activities | -$32.8M | -$50.8M | -$60.4M | -$26.1M | -$22.0M | -$5.5M |
| Net Cash Provided By Used In Financing Activities | $10.7M | $3.6M | $146.0K | $1.2M | $478.9M | $5.8M |
| Net Cash Provided By Used In Investing Activities | -$1.1M | $28.6M | $26.2M | $88.8M | -$411.6M | -$2.1M |
| Share Based Compensation | $8.9M | $10.1M | $9.4M | $7.2M | $5.8M | $1.6M |
| Proceeds From Research And Development Program | $1.7M | $8.1M | $0.00 | $849.0K | $543.0K | $2.7M |
| Payments To Acquire Property Plant And Equipment | $30.2M | $9.0M | $102.2M | $83.7M | $12.3M | $1.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $272.0K | -$2.4M | $5.0M | -$432.0K | $3.7M | -$53.0K |
| Increase Decrease In Accounts Payable | -$1.2M | $373.0K | $909.0K | $26.0K | -$395.0K | $1.2M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$182.0K | -$480.0K | $1.1M | -$2.8M | -$14.0K | -$52.0K |
| Depreciation Depletion And Amortization | $11.2M | $10.7M | $3.4M | $711.0K | $544.0K | $479.0K |
| Proceeds From Sale Of Available For Sale Securities Debt | $1.08B | $1.75B | $3.61B | $3.82B | $2.02B | $0.00 |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $17.6M | $103.3M | $157.4M | $180.3M | $25.1M | $0.00 |
| Payments To Acquire Available For Sale Securities Debt | $1.07B | $1.82B | $3.63B | $3.82B | $2.45B | $0.00 |
| Increase Decrease In Other Current Liabilities | -$154.0K | -$1.4M | $65.0K | -$329.0K | $380.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accrued Liabilities | $1.4M | -$2.0M | $117.0K | $1.5M | $901.0K | $9.1K | ||||
| Net Cash Provided By Used In Operating Activities | -$8.4M | -$16.7M | -$19.1M | -$1.3M | -$3.4M | |||||
| Net Cash Provided By Used In Financing Activities | -$4.5M | $6.6M | $33.0K | $34.0K | $11.8M | $0.00 | ||||
| Net Cash Provided By Used In Investing Activities | $540.0K | $9.3M | -$1.8M | $13.1M | -$793.0K | |||||
| Share Based Compensation | $2.3M | $2.8M | $2.2M | $918.0K | $627.0K | |||||
| Proceeds From Research And Development Program | $0.00 | $0.00 | $0.00 | $8.1M | $0.00 | $0.00 | $10.0K | $0.00 | $74.0K | |
| Payments To Acquire Property Plant And Equipment | $7.0M | $1.9M | $41.0M | $10.4M | $741.0K | |||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$300.0K | -$31.0K | $550.0K | -$1.2M | $2.0K | |||||
| Increase Decrease In Accounts Payable | $130.0K | $580.0K | -$110.0K | $637.0K | $31.0K | |||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$31.0K | $1.0M | -$40.0K | -$533.0K | -$100.0K | |||||
| Depreciation Depletion And Amortization | $2.7M | $2.3M | $288.0K | $148.0K | $115.0K | |||||
| Proceeds From Sale Of Available For Sale Securities Debt | $282.4M | $441.4M | $1.00B | $1.24B | $0.00 | |||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $5.1M | $13.3M | $67.0M | $37.7M | $0.00 | |||||
| Payments To Acquire Available For Sale Securities Debt | $280.0M | $443.5M | $1.03B | $1.26B | $0.00 | |||||
| Increase Decrease In Other Current Liabilities | $134.0K | -$590.0K | $680.0K | -$290.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$50.55 | -$17.54 | $0.17 | $0.55 | $0.40 | -$0.48 |
| Weighted Average Number Of Shares Outstanding Basic | 4.9M | 4.8M | 139.7M | 137.6M | 101.2M | 62.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 4.9M | 4.8M | 142.7M | 142.1M | 106.2M | 62.5M |
| Earnings Per Share Basic | $-50.55 | $-17.54 | $0.17 | $0.57 | $0.42 | $-0.48 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Shares Outstanding | 5.2M | 5.0M | 145.7M | 143.0M | 141.3M | 70.3M |
| Common Stock Shares Issued | 5.2M | 5.0M | 145.7M | 143.0M | 141.3M | 70.3M |
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Sponsor Vesting Shares Outstanding | 50.0K | 100.0K | 4.5M | 4.5M | 4.5M | |
| Sponsor Vesting Shares Issued | 50.0K | 100.0K | 4.5M | 4.5M | 4.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.11 | -$0.09 | -$0.18 | -$0.26 | -$0.14 | -$0.10 | $0.22 | -$0.05 | $0.07 | $0.06 | $0.33 | $0.05 | $0.20 | $0.63 | -$0.86 | -$0.05 | -$0.03 |
| Weighted Average Number Of Shares Outstanding Basic | 149.3M | 147.8M | 146.9M | 143.4M | 143.0M | 141.8M | 139.8M | 139.3M | 138.7M | 138.1M | 137.1M | 136.8M | 136.7M | 67.5M | 62.7M | 62.5M | 62.5M |
| Weighted Average Number Of Diluted Shares Outstanding | 149.3M | 147.8M | 146.9M | 143.4M | 143.0M | 141.8M | 142.7M | 139.3M | 142.5M | 142.2M | 142.2M | 141.7M | 141.2M | 78.6M | 62.7M | 62.5M | 62.5M |
| Earnings Per Share Basic | $-0.11 | $-0.09 | $-0.18 | $-0.26 | $-0.14 | $-0.10 | $0.22 | $-0.05 | $0.07 | $0.06 | $0.34 | $0.05 | $0.20 | $0.93 | $-0.86 | $-0.05 | $-0.03 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Shares Outstanding | 150.5M | 150.2M | 149.5M | 145.9M | 147.2M | 146.5M | 144.2M | 143.5M | 143.3M | 142.7M | 142.4M | 141.4M | 136.8M | 136.7M | |||
| Common Stock Shares Issued | 150.5M | 150.2M | 149.5M | 145.9M | 147.2M | 146.5M | 144.2M | 143.5M | 143.3M | 142.7M | 142.4M | 141.4M | 136.8M | 136.7M | |||
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Sponsor Vesting Shares Outstanding | 1.5M | 3.0M | 3.0M | 3.0M | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M | |||||
| Sponsor Vesting Shares Issued | 1.5M | 3.0M | 3.0M | 3.0M | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $8.9M | $10.1M | $11.6M | $9.1M | $5.8M | $1.6M |
| Additional Paid In Capital | $402.4M | $393.2M | $382.9M | $371.1M | $361.5M | $98.6M |
| Depreciation And Amortization | $11.2M | $10.7M | $3.4M | $711.0K | $544.0K | $479.0K |
| Stock Issued During Period Value Stock Options Exercised | $253.0K | $252.0K | $146.0K | $401.0K | $77.0K | $2.0K |
| Change In Fair Value Of Derivatives | -$15.0K | $290.0K | $69.0K | -$443.0K | $1.3M | $1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.2M | $2.3M | $2.3M | $2.5M | $2.5M | $2.8M | $3.1M | $3.0M | $2.9M | $1.4M | $1.8M | $1.2M | $636.0K | $3.5M | $627.0K | $60.0K | $9.0K | $9.0K |
| Additional Paid In Capital | $400.3M | $397.8M | $395.5M | $390.9M | $388.4M | $385.7M | $380.3M | $377.1M | $374.0M | $366.3M | $364.9M | $362.8M | $360.6M | $359.9M | $14.7M | $5.1M | $23.2K | |
| Depreciation And Amortization | $2.8M | $2.8M | $2.7M | $2.8M | $2.8M | $2.3M | $386.0K | $347.0K | $288.0K | $180.0K | $160.0K | $148.0K | $126.0K | $121.0K | $115.0K | $102.0K | $100.0K | |
| Stock Issued During Period Value Stock Options Exercised | $196.0K | $57.0K | $4.0K | $158.0K | $83.0K | $90.0K | $31.0K | $23.0K | $103.0K | $234.0K | $34.0K | $2.0K | $55.0K | $1.0K | ||||
| Change In Fair Value Of Derivatives | $17.0K | $6.0K | -$38.0K | -$43.0K | -$16.0K | $296.0K | $126.0K | -$266.0K | $760.0K | $1.1M | $1.4M | $834.0K | $0.00 | $1.0M | $391.0K |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.